Pharming Group N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHARM.AS research report →
About the company
Based in Leiden, the Netherlands, Pharming Group N. V. operates as a biopharmaceutical firm dedicated to advancing and marketing protein replacement therapies and precise medical solutions.
- CEO
- Fabrice Chouraqui
- IPO
- 1999
- Employees
- 404
- HQ
- Leiden, NL
Price Chart
- Market Cap
- $812.19M
- P/E
- 66.79
- P/S
- 2.49
- P/B
- 3.60
- EV/EBITDA
- 29.13
- Div Yield
- 0.00%
- Gross Margin
- 88.12%
- Op Margin
- 6.36%
- Net Margin
- 3.37%
- ROE
- 4.75%
- ROIC
- 3.76%
- Revenue
- $376.13M · 26.62%
- Net Income
- $2.97M · 126.92%
- EPS
- $0.00 · 125.79%
- Op Income
- $20.88M
- FCF YoY
- 2080.83%
- 52W High
- $1.82
- 52W Low
- $0.84
- 50D MA
- $1.22
- 200D MA
- $1.35
- Beta
- 0.10
- Avg Volume
- 11.53M
Get TickerSpark's AI analysis on PHARM.AS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PHARM.AS coverage
Recent articles, reports, and earnings notes.
No research on PHARM.AS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHARM.AS report →Similar companies
Peers in the same neighborhood.